Abstract
Patients with worsening heart failure (WHF) have increased risk of future WHF events and death. In clinical trials, guideline directed medical therapy (GDMT) reduces this risk, but few patients in the real-world receive optimal GDMT, rendering its effectiveness unclear.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
